Building on the performance of Dexcom’s biosensing technology, we are excited to announce the upcoming launch of Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes in the United States. Starting Dec. 1, Dexcom G7 15 Day will be available for users who receive their Dexcom CGM through DME providers. Dexcom G7 15 Day will also be covered for Medicare beneficiaries and has met the category requirements for therapeutic CGM systems set forth by the U.S. Centers for Medicare & Medicaid Services. Dexcom G7 15 Day is designed to provide real-time glucose readings for an industry-leading 15.5 days*† and continues to evolve Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range, and serves as a significant advancement in glucose management for people with diabetes. Click the link to learn more about Dexcom G7 15 Day: https://lnkd.in/duAT4aij * A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per package labeling, approximately 26% of sensors may not last for the full 15 days. †Excludes implantable CGM systems.
What contractual obligations do DMEs have for providing a 90-supply of sensors? Nine sensors for a 90-day period was already questionable; if the implication is that we will be given 6 15-day sensors (with a <74% chance of lasting the full period), this will be far more trouble than it is worth.
Hi Dexcom. This appears to be a great step forward for users but I hope there have been huge improvements in QA and QC of products in the new 15 day units. For example, it's often a struggle to get close to 10 days usage with the current model, there are also recurring issues with the filament coming through the hole upon application. Also, with the change to 3 goodwill replacements a year, sensor falling off is not seen as a "fault" and therefore not replaced. With less than 74% of sensors lasting 15 days in your clinical trial conditions, this would result in patients being left with potentially 1 week out of every 4 without a working sensor which will not be replaced by Dexcom, even more if there have not been the necessary improvements to your adhesive which struggles to last 10 days currently. If it works however, this is a huge bonus for diabetics.
Who was asking for extended sensor durations and what value do you see from it?
Congratulations Dexcom, appreciate this was always the intention with the G7; no doubt accelerated due to Abbott Libre 3 offering a longer life; now matched. Main question is why is the longer life only in the USA? UK and Swiss regulators are now aligned with the FDA and visa versa.
Awesome news for people living with diabetes !
Absolute game changer
Exciting!
An impressive development in diabetes care! The launch of the Dexcom G7 15 Day Continuous Glucose Monitoring System marks a significant advancement in real-time glucose management for adults living with diabetes in the United States. With its industry-leading 15.5-day sensor life and coverage through Durable Medical Equipment providers as well as Medicare, this innovation is set to enhance glucose control by helping to reduce A1C levels, hyperglycemia, and hypoglycemia while increasing time in range. This progress reflects a meaningful step forward in improving patient outcomes and quality of life for the diabetes community. 👏🔬💡 For More, visit our page: marketaccesstoday.com #ContinuousGlucoseMonitoring #Dexcom #DiabetesCare #HealthcareInnovation #MedicalTechnology #MarketAccess #MarketAccessToday
Hopefully there are quality improvements being made as well. I'm often struggling to get the G7 to last even 10 days without errors such as the filament falling out. I've unfortunately had more faulty sensors in a couple of months on G7 than I did in 7 years on G6. My experience is not unique either.